Expanded Molecular Assay Menu

About Hologic

Hologic is a mission-driven leader in women's healthcare technology, founded in 1985 and publicly traded on NASDAQ. The company has achieved market leadership through its gold-standard 3D mammography systems and high-throughput molecular diagnostics platforms, establishing a comprehensive continuum of care. Its strategy focuses on innovation within its core platforms, global expansion, and strategic acquisitions, recently underscored by a definitive agreement to be acquired by private equity firms Blackstone and TPG for up to $79 per share, signaling strong confidence in its future growth and stability.

Therapeutic Areas